Ragaglitazar: The Pharmacokinetics, Pharmacodynamics, and Tolerability of a Novel Dual PPAR[H9251] and Agonist in Healthy Subjects and Patients with Type 2 Diabetes
Titel:
Ragaglitazar: The Pharmacokinetics, Pharmacodynamics, and Tolerability of a Novel Dual PPAR[H9251] and Agonist in Healthy Subjects and Patients with Type 2 Diabetes
Auteur:
Skrumsager, B. K. Nielsen, K. K. Müller, M. Pabst, G. Drake, P. G. Edsberg, B.